Compound heterozygous variation of PATL2 causes oocyte maturation defect

doi:10.16352/j.issn.1001-6325.2022.01.004

Abstract

Abstract: Objective To investigate the genetic etiology of a patient with primary infertility and oocyte maturation defect. Methods Whole exome sequencing (WES) was carried out on patient's DNA to detect potential pathologic variants. The positive sites detected by WES were verified by Sanger sequencing, and the bioinformatics analysis of the mutation was analyzed. Results The patient was found to harbor compound heterozygous variants of the PATL2 in exon 14 and 13 c.1 374A＞G (p.Ile458Met) and c.1 289_1 291delTCC (p.Leu430del), which were respectively inherited from her father and mother. Conclusions The compound heterozygous variation of PATL2 may be the genetic mechanism to explain infertility resulted from the disturbance of oocyte maturation.

Key words: PATL2 gene, oocyte maturation defect

CLC Number:

R394

HUO Ming-zhu, ZHANG Yi-le, XU Jia-wei, SHI Hao, LIU Yi-dong, NIU Wen-bin. Compound heterozygous variation of PATL2 causes oocyte maturation defect[J]. Basic & Clinical Medicine, 2022, 42(1): 51-55.

References

[1]Mehlmann LM. Stops and starts in mammalian oocytes: recent advances in understanding the regulation of meiotic arrest and oocyte maturation[J]. Reproduction, 2005, 130: 791-799.
[2]Szöllösi D. Oocyte maturation and paternal contribution to the embryo in mammals[J]. Curr Top Pathol, 1976, 62:9-27.
[3]Beall S, Brenner C, Segars J. Oocyte maturation failure: a syndrome of bad eggs[J]. Fertil and steril, 2010, 94: 2507-2513.
[4]Maddirevula S, Coskun S, Alhassan S, et al. Female infertility caused by mutations in the oocyte-specific translational repressor PATL2[J]. Am J Hum Genet, 2017, 101: 603-608.
[5]Radford HE, Meijer HA, de Moor CH. Translational control by cytoplasmic polyadenylation in Xenopus oocytes[J]. Biochim Biophys Acta, 2008, 1779: 217-229.
[6]Nakamura Y, Tanaka KJ, Miyauchi M, et al. Transla-tional repression by the oocyte-specific protein P100 in Xenopus[J]. Dev Biol, 2010, 344: 272-283.
[7]Liu Z, Zhu L, Wang J, et al. Novel homozygous mutations in PATL2 lead to female infertility with oocyte maturation arrest[J]. J Assist Reprod Genet, 2020, 37: 841-847.
[8]Chen B, Zhang Z, Sun X, et al. Biallelic mutations in PATL2 cause female infertility characterized by oocyte maturation arrest[J]. Am J Hum Genet, 2017, 101: 609-615.
[9]Christou-Kent M, Kherraf ZE, Amiri-Yekta A, et al. PATL2 is a key actor of oocyte maturation whose invalidation causes infertility in women and mice[J]. EMBO Mol Med, 2018, 10: e8515.doi:10.15252.
[10]Huang L, Tong X, Wang F, et al. Novel mutations in PATL2 cause female infertility with oocyte germinal vesicle arrest[J]. Hum Reprod, 2018, 33: 1183-1190.
[11]Rother RP, Frank MB, Thomas PS. Purification, primary structure, bacterial expression and subcellular distribution of an oocyte-specific protein in Xenopus[J]. Eur J Biochem, 1992, 206: 673-683.
[12]Wu L, Chen H, Li D, et al. Novel mutations in PATL2: expanding the mutational spectrum and corresponding phenotypic variability associated with female infertility[J]. J Hum Genet, 2019, 64: 379-385.
[13]Zhang Z, Li B, Fu J, et al. Bi-allelic missense pathogenic variants in TRIP13 cause female infertility characterized by oocyte maturation arrest[J]. Am J Hum Genet, 2020, 107: 15-23.

[1]	ZHANG Lei, JI Peili, YUE Cai, ZHAO Xiuli, LIU Yaping, CHEN Limeng. Application of flipped classroom combined with a case-based learning in genetics courses [J]. Basic & Clinical Medicine, 2024, 44(9): 1331-1334.
[2]	LIU Siyi, YANG Yujiao, YANG Tao, ZHAO Xiuli. Identification of the causative variants in five Chinese families with tuberous sclerosis complex [J]. Basic & Clinical Medicine, 2024, 44(3): 361-367.
[3]	LIU Aixia, ZHANG Hao, SUN Jie, YANG Lihua, ZHAO Xiaotao. The role of GPS2 in regulating proliferation, migration and invasion of hepatocellular carcinoma cell line MHCC-97H [J]. Basic & Clinical Medicine, 2023, 43(12): 1784-1791.
[4]	ZHANG Liangliang, ZHAO Chengjin, ZHOU Yuhu, CAO Bo, DUAN Mingming, FENG Yangyang. LncRNA FGD5-AS1 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells by regulating miR-93-5p/BMP2 axis [J]. Basic & Clinical Medicine, 2023, 43(8): 1179-1185.
[5]	KOU Yu-hui, YE Cai-ying, XING Cheng-feng. Advances in research of Blau syndrome [J]. Basic & Clinical Medicine, 2022, 42(12): 1945-1949.
[6]	TENG Cong-cong, XU Yong-mei, TANG Shu-ping, LI Yong, YANG Yang, LONG Lan, ZHANG Jie. Epidemiological investigation of thalassemia in gestational age population of Dai nationality in Dehong Prefecture, Yunnan Province [J]. Basic & Clinical Medicine, 2022, 42(10): 1504-1508.
[7]	GUO Jing, LI Ya-jie, MOU Han-shuang. LncRNA FGD5-AS1 reduces ox-LDL-induced damage of HUVECs by targeting miR-106a-5p [J]. Basic & Clinical Medicine, 2022, 42(5): 768-775.
[8]	ZHANG Yan, ZHU Meng-wen, LIU Tong, YANG Sheng, LIANG Ge-yu. Research progress on the role of N6-methyladenosine (m6A) RNA modification in reproductive system diseases [J]. Basic & Clinical Medicine, 2021, 41(9): 1347-1351.
[9]	JIANG Xue-dong, LI Wen-ya. Erastin induces cell apoptosis in human non-small cell lung cancer cell line A549 [J]. Basic & Clinical Medicine, 2021, 41(9): 1313-1317.
[10]	YAO Han, XU Wen-bin, WANG Dong-lai. Anti-tumor drug FTY720 regulates p53-dependent transcription [J]. Basic & Clinical Medicine, 2021, 41(3): 311-317.
[11]	LI Ming-yang, WANG Shu-xia, ZHAO Jing-miao, WANG Qiu-ping, CHEN Ping, JIN Hua, HU Ji-hong. Effects of 5-Aza-induced BM-MSCs transplantation on myocardial infarction area, related cytokines and potassium ion channels in rats [J]. Basic & Clinical Medicine, 2021, 41(1): 20-26.
[12]	GAO Dong-xiao, LIU Dan, GUO Qiang, LUO Ying, LIU Jing. Research progress of biological clock in regulation of tumor development [J]. Basic & Clinical Medicine, 2020, 40(11): 1561-1564.
[13]	MI Ya-jing, ZHANG Ni, FENG Hao, LIU Jie, GOU Xing-chun, JING Xiao-hong. Exploration of strengthening the cultivation of ethical quality in the construction of medical genetics course [J]. Basic & Clinical Medicine, 2020, 40(10): 1435-1438.
[14]	NI An-ni, LIANG Qing-yang, YAO Hong-fei, LI Gen-liang, TANG Yu-lian. Effect of arachidonic acid metabolism gene on cyclooxygenase P450 pathway in hepatocellular carcinoma of mice [J]. Basic & Clinical Medicine, 2020, 40(8): 1053-1058.
[15]	HU Jing-cen, LI Lian, WANG Shu-yu, XU Lei, YANG De-lun, HAN Li-yuan, XU Guo-dong. Association between SHMT1 gene promoter methylation and ischemic stroke [J]. Basic & Clinical Medicine, 2020, 40(4): 451-455.